Filing Details

Accession Number:
0000899243-19-017486
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-06-19 19:04:13
Reporting Period:
2019-05-23
Accepted Time:
2019-06-19 19:04:13
Original Submission Date:
2019-05-28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
730272 Repligen Corp RGEN Biological Products, (No Disgnostic Substances) (2836) 042729386
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1046351 Md L Glenn Cooper C/o Repligen Corporation
41 Seyon St., Bldg 1, Ste 100
Waltham MA 02453
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-05-23 24,000 $5.00 64,709 No 4 M Direct
Common Stock Disposition 2019-05-23 4,734 $66.91 59,975 No 4 S Direct
Common Stock Disposition 2019-05-23 266 $67.53 59,709 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-05-23 24,000 $0.00 24,000 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-08-24 No 4 M Direct
Footnotes
  1. Sale of common stock to cover the exercise price and a portion of the tax liability resulting from the exercise of Mr. Cooper's stock options was allowed pursuant to an exception to a lock-up agreement, signed by Mr. Cooper on April 26, 2019 in connection with the public offering of the Company's common stock.
  2. $66.91 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.42 to $67.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. $67.53 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.52 to $67.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. This option is currently exercisable.